Arrowhead Pharmaceuticals Presents Interim Clinical Data on ARO-CFB for the Treatment of Complement Mediated Diseases
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced interim results from a Phase 1/2a clinical study of ARO-CFB, the company’s investigational RNA interference (RNAi) therapeutic targeting ...
Arrowhead announces interim results from ARO-CFB study
Arrowhead (ARWR) announced interim results from a Phase 1/2a clinical study of ARO-CFB, the company’s investigational RNA interference, or ...
Shareholders in Arrowhead Pharmaceuticals (NASDAQ:ARWR) have lost 66%, as stock drops 9.3% this past week
Arrowhead Pharmaceuticals, Inc. ( NASDAQ:ARWR ) shareholders should be happy to see the share price up 11% in the ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Shares Sold by Fmr LLC
Fmr LLC cut its position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) by 10.9% in the third quarter, ...
Charles Schwab Investment Management Inc. Grows Stock Position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR)
Charles Schwab Investment Management Inc. increased its stake in shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – ...
TD Cowen Keeps Their Hold Rating on Recursion Pharmaceuticals (RXRX)
In a report released today, Brendan Smith from TD Cowen maintained a Hold rating on Recursion Pharmaceuticals (RXRX – Research Report). The ...
Le Lézard14h
Condado Tacos is spicing up their growth plan with a new secret ingredient: PAR Technology's Data Central
PAR Technology , a global foodservice technology company, today announces that Condado Tacos, the rapidly growing restaurant brand celebrated for its custom tacos and bold flavors, has selected PAR® ...
Le Lézard14h
ImmunityBio, Inc. Announces Pricing of Public Offering of Common Stock
ImmunityBio, Inc. , a leading immunotherapy company, today announced the pricing of its previously announced underwritten public offering of an aggregate of 33,333,334 shares of its common stock at a ...